Chembio Will Benefit from High COVID-19 Antibody Testing Demand
Will Chembio’s DPP COVID-19 system gain and sustain commercial success? How will sensitivity and specificity concerns impact adoption of COVID-19 point-of-care tests?
Report Date :
06/12/2020
Topic :
Chembio Diagnostics
Source Silos :
1) Medical diagnostic professionals
2) Diagnostic testing sales, distribution channels
3) COVID-19 testing and public health professionals
4) Industry specialists
5) Secondary sources
Sector :
Health Care
Companies :
ABT, BIM.PA, CEMI, DGX, LH, RHHBY, TMO, 688298:SHA
Industry :
Health Care Equipment & Supplies
Chembio Will Benefit from High COVID-19 Antibody Testing Demand PDF